185 related articles for article (PubMed ID: 37089593)
1. Incidence of cutaneous melanoma and Merkel cell carcinoma in patients with primary cutaneous B-cell lymphomas: A population study of the SEER registry.
Banner L; Joffe D; Lee E; Porcu P; Nikbakht N
Front Med (Lausanne); 2023; 10():1110511. PubMed ID: 37089593
[TBL] [Abstract][Full Text] [Related]
2. Risk of Multiple Primary Cancers in Patients With Merkel Cell Carcinoma: A SEER-Based Analysis.
Eid E; Maloney NJ; Cai ZR; Zaba LC; Kibbi N; John EM; Linos E
JAMA Dermatol; 2023 Nov; 159(11):1248-1252. PubMed ID: 37703005
[TBL] [Abstract][Full Text] [Related]
3. Primary Cutaneous B-Cell Lymphomas in Children and Adolescents: A SEER Population-Based Study.
Bomze D; Sprecher E; Goldberg I; Samuelov L; Geller S
Clin Lymphoma Myeloma Leuk; 2021 Dec; 21(12):e1000-e1005. PubMed ID: 34417159
[TBL] [Abstract][Full Text] [Related]
4. Merkel cell carcinoma and multiple primary cancers.
Howard RA; Dores GM; Curtis RE; Anderson WF; Travis LB
Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1545-9. PubMed ID: 16896047
[TBL] [Abstract][Full Text] [Related]
5. Primary Cutaneous B-Cell Lymphoma: Management and Patterns of Recurrence at the Multimodality Cutaneous Lymphoma Clinic of The Ohio State University.
Haverkos B; Tyler K; Gru AA; Winardi FK; Frederickson J; Hastings J; Elkins C; Zhang X; Xu-Welliver M; Wong HK; Porcu P
Oncologist; 2015 Oct; 20(10):1161-6. PubMed ID: 26306900
[TBL] [Abstract][Full Text] [Related]
6. Merkel cell carcinoma: incidence, mortality, and risk of other cancers.
Kaae J; Hansen AV; Biggar RJ; Boyd HA; Moore PS; Wohlfahrt J; Melbye M
J Natl Cancer Inst; 2010 Jun; 102(11):793-801. PubMed ID: 20424236
[TBL] [Abstract][Full Text] [Related]
7. Mutual Risks of Cutaneous Melanoma and Specific Lymphoid Neoplasms: Second Cancer Occurrence and Survival.
Herr MM; Schonfeld SJ; Dores GM; Withrow DR; Tucker MA; Curtis RE; Morton LM
J Natl Cancer Inst; 2018 Nov; 110(11):1248-1258. PubMed ID: 29659938
[TBL] [Abstract][Full Text] [Related]
8. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous lymphomas: an update. Part 2: B-cell lymphomas and related conditions.
Kempf W; Kazakov DV; Mitteldorf C
Am J Dermatopathol; 2014 Mar; 36(3):197-208; quiz 209-10. PubMed ID: 24658377
[TBL] [Abstract][Full Text] [Related]
10. Primary cutaneous B-cell lymphomas: recent advances in diagnosis and management.
Sokol L; Naghashpour M; Glass LF
Cancer Control; 2012 Jul; 19(3):236-44. PubMed ID: 22710899
[TBL] [Abstract][Full Text] [Related]
11. New Insights into Macular Type of Primary Cutaneous B-Cell Lymphoma: Extension of the Clinical and Histopathological Patterns.
Barzilai A; Amitay-Laish I; Didkovsky E; Feinmesser M; Dalal A; Schiby G; Hodak E
Dermatology; 2022; 238(6):1018-1025. PubMed ID: 35817021
[TBL] [Abstract][Full Text] [Related]
12. Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study.
Spanogle JP; Clarke CA; Aroner S; Swetter SM
J Am Acad Dermatol; 2010 May; 62(5):757-67. PubMed ID: 20223559
[TBL] [Abstract][Full Text] [Related]
13. Risk of second cancers after the diagnosis of Merkel cell carcinoma in Scandinavia.
Bzhalava D; Bray F; Storm H; Dillner J
Br J Cancer; 2011 Jan; 104(1):178-80. PubMed ID: 21081931
[TBL] [Abstract][Full Text] [Related]
14. Merkel cell carcinoma and melanoma: etiological similarities and differences.
Miller RW; Rabkin CS
Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):153-8. PubMed ID: 10067813
[TBL] [Abstract][Full Text] [Related]
15. Abnormal AP-1 protein expression in primary cutaneous B-cell lymphomas.
Mao X; Orchard G
Br J Dermatol; 2008 Jul; 159(1):145-51. PubMed ID: 18460027
[TBL] [Abstract][Full Text] [Related]
16. Spectrum of Nonkeratinocyte Skin Cancer Risk Among Solid Organ Transplant Recipients in the US.
Sargen MR; Cahoon EK; Yu KJ; Madeleine MM; Zeng Y; Rees JR; Lynch CF; Engels EA
JAMA Dermatol; 2022 Apr; 158(4):414-425. PubMed ID: 35262623
[TBL] [Abstract][Full Text] [Related]
17. Primary cutaneous B-cell lymphomas: part II. Therapy and future directions.
Suárez AL; Querfeld C; Horwitz S; Pulitzer M; Moskowitz A; Myskowski PL
J Am Acad Dermatol; 2013 Sep; 69(3):343.e1-11; quiz 355-6. PubMed ID: 23957985
[TBL] [Abstract][Full Text] [Related]
18. Second cancers following the diagnosis of Merkel cell carcinoma: a nationwide cohort study.
Koljonen V; Kukko H; Tukiainen E; Böhling T; Sankila R; Joensuu H; Pukkala E
Cancer Epidemiol; 2010 Feb; 34(1):62-5. PubMed ID: 20061203
[TBL] [Abstract][Full Text] [Related]
19. Clinical features and treatment outcomes of primary cutaneous B-cell lymphoma: a single-center analysis in South Korea.
Kim MJ; Hong ME; Maeng CH; Jung HA; Hong JY; Choi MK; Kim SJ; Ko YH; Kim WS
Int J Hematol; 2015 Mar; 101(3):273-8. PubMed ID: 25552248
[TBL] [Abstract][Full Text] [Related]
20. Second Primary Malignancies in Patients With Melanoma Subtypes: Analysis of 120,299 Patients From the SEER Database (2000-2016).
Loya A; Gombos DS; Patel SP
Front Oncol; 2022; 12():853076. PubMed ID: 35372013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]